CNV

Clinical trials for CNV explained in plain language.

Never miss a new study

Get alerted when new CNV trials appear

Sign up with your email to follow new studies for CNV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

One-Shot gene therapy could end monthly eye injections for wet AMD

Disease control Recruiting now

This study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 714 adults aged 50-89 who currently need regular eye injections will receive either the gene therapy or standard treatment. The goal is to…

Matched conditions: CNV

Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated Jun 27, 2026 12:10 UTC

CNV

Get alerted when new CNV trials appear

One-Shot gene therapy could end monthly eye injections for wet AMD